Spain Canada Poland Finland covid-19 testing vaccine Spain Canada Poland Finland

Pfizer to study COVID-19 vaccine in children under 12

Reading now: 359
globalnews.ca

Pfizer Inc said on Tuesday it will start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial.The study will enroll up to 4,500 children at more than 90 clinical sites in the United States, Finland, Poland and Spain, the company said.Pfizer’s vaccine has been authorized for use in children as young as 12 in Europe, the United States and Canada.The company said it has selected a dose of 10 micrograms in children between five and 11 years of age and three micrograms for infants in age-group of six months to five years -old.Inoculating children and young people is considered a critical step toward reaching “herd immunity” and taming the COVID-19 pandemic..

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA